Publications Repository

Publications Repository

View item 
  •   Home
  • ICR Divisions
  • Other ICR Research
  • View item
  • Home
  • ICR Divisions
  • Other ICR Research
  • View item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Ethical approval for multicentre clinical trials in children: contrasting systems in three European countries

Thumbnail
Date
2002-05
ICR Author
Pinkerton, Ross
Author
Pinkerton, CR
Ablett, S
Boos, J
Philip, T
Type
Journal Article
Metadata
Show full item record
Abstract
Pan-European collaboration in studies of novel therapies and treatment strategies in childhood cancer is playing an increasing role in the attempt to improve cure rates. Differences in the systems of various Countries with regard to drug control and ethical issues may lead to problems and delays. This applies in particular to phase I/II studies in children where the ethical considerations may be complex. In this review, the systems in three large countries-UK, France and Germany-are reviewed and current moves within the European Community towards a more standard approach are discussed. (C) 2002 Elsevier Science Ltd. All rights reserved.
URI
https://repository.icr.ac.uk/handle/internal/2804
DOI
https://doi.org/10.1016/S0959-8049(02)00021-7
Collections
  • Other ICR Research
Language
eng
License start date
2002-05
Citation
EUROPEAN JOURNAL OF CANCER, 2002, 38 pp. 1051 - 1058

Browse

All of ICR repositoryICR DivisionsBy issue dateAuthorsTitlesPublication TypesThis collectionBy issue dateAuthorsTitlesPublication Types
  • Login
  • Registered office: The Institute of Cancer Research, 123 Old Brompton Road, London, SW7 3RP
    A Charity, Not for Profit. Company Limited by Guarantee.
    Registered in England No. 534147. VAT Registration No. GB 849 0581 02.